loader

nasdaq:mygn

LATEST ARTICLES

Myriad Genetics Submits First Module of Premarket Approval Application to FDA for myChoice® HRD CDx Test

Myriad Validates Polygenic Score to Predict Breast Cancer Risk

Myriad Presents Two New Studies at the Western Section of the American Urological Association

New Studies Highlight Performance of Vectra Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab

Myriad Announces New Laboratory Agreement with Pfizer

NASDAQ:MYGN

Myriad Receives FDA SPMA Approval for BRACAnalysis CDx

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES